Levosimendan in acute decompensation of anthracycline-induced cardiotoxicity.
Garcia
José A P
JA
Simvoulidis
Luiz F N
LF
Salluh
Jorge I F
JI
Hansen
Maria H A
MH
Feres
Guilherme A
GA
Holanda
Gustavo S
GS
Souza
Roberto C S
RC
Toscano
Luisa
L
Soares
Márcio
M
D000208:Acute Disease; D000328:Adult; D018943:Anthracyclines / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D011724:Pyridazines / Q000008:administration & dosage*; D000077464:Simendan; D016896:Treatment Outcome
D018943:Anthracyclines; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan